Use of a program-specific website to disseminate surveillance data obtained from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Study
- 31 December 2005
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 53 (4) , 273-279
- https://doi.org/10.1016/j.diagmicrobio.2005.10.005
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pathogens resistant to antimicrobial agents: Epidemiology, molecular mechanisms, and clinical managementInfectious Disease Clinics of North America, 2004
- Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: Report of year five (2003)Diagnostic Microbiology and Infectious Disease, 2004
- Appropriate antimicrobial treatment in nosocomial infections—the clinical challengesJournal of Hospital Infection, 2003
- Appropriate Empirical Antibacterial Therapy for Nosocomial InfectionsDrugs, 2003
- Antibiotic resistance surveillance: action for international studiesJournal of Antimicrobial Chemotherapy, 2002
- Determining the value of antimicrobial surveillance programsDiagnostic Microbiology and Infectious Disease, 2001
- MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview.Journal of Antimicrobial Chemotherapy, 2000
- Surveillance studies: how can they help the management of infection?Journal of Antimicrobial Chemotherapy, 2000
- Inadequate Antimicrobial Treatment of InfectionsChest, 1999
- Antimicrobial Resistance in Isolates from Inpatients and Outpatients in the United States: Increasing Importance of the Intensive Care UnitClinical Infectious Diseases, 1997